Tauvid: New Alzheimer’s Focused PET Radiopharmaceutical
Recently, the FDA provided approval for the use of two new PET radiopharmaceuticals, Cerianna and Tauvid. Cerianna is a molecular imaging agent indicated for use
DMS carries systems across multiple modalities and from a wide range of manufacturers including Philips, GE, Digirad, Siemens, Hologic, and more.
Interim Imaging from DMS Health is provided using a mobile trailer that is delivered to your facility. The imaging space is fully equipped, furnished and ready for patients. All you need to provide is power and data to get started.
The Interim Imaging Planning Guide is a resource that covers how interim imaging works and common mistakes to avoid before choosing a provider. Download your free copy today!
Mobile Imaging with DMS a great way to establish a new service line, build volumes, or expand offerings at multiple locations. DMS offers mobile MRI, CT, PET/CT, Ultrasound, Bone Densitometry, Nuclear Medicine, and more.
Recently, the FDA provided approval for the use of two new PET radiopharmaceuticals, Cerianna and Tauvid. Cerianna is a molecular imaging agent indicated for use
This post was written by John W. Mitchell and first appeared on DOTmed HealthCare Business Daily News. It has been reposted here with permission of
Prostate cancer is a leading cause of death among US men. Advances in imaging are helping to detect it earlier – here is where prostate imaging is heading.
CONNECT WITH DMS
©2020 DMS Health Technologies
